Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration
Abstract We investigated the association between von Willebrand factor (VWF) and exudative age-related macular degeneration (AMD) in 114 Japanese patients. Intravitreal injection of vascular endothelial growth factor (VEGF) inhibitor is the most effective therapy for AMD. Therefore, we analyzed chan...
Enregistré dans:
Auteurs principaux: | Mariko Yamashita, Masanori Matsumoto, Masaki Hayakawa, Kazuya Sakai, Yoshihiro Fujimura, Nahoko Ogata |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/995d2842aecf46f6b17a2d1916c57f4d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Analysis focusing on plasma von Willebrand factor in pachychoroid neovasculopathy and age-related macular degeneration
par: Hiromasa Hirai, et autres
Publié: (2021) -
Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
par: Yamashita M, et autres
Publié: (2014) -
Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy.
par: Kei Takayama, et autres
Publié: (2021) -
Von Willebrand Disease in the elderly: clinical perspectives
par: Chapin J
Publié: (2018) -
Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
par: Ingrid Skornova, et autres
Publié: (2021)